Cullinan Therapeutics Inc banner

Wall St Price Targets

CGEM Price Forecast
Based on 14 analysts

+150% Upside
from $14.46 today

Cullinan Therapeutics Inc (CGEM)’s 12-month stock price forecast through October 2027 has a consensus target of $36.21, implying 150% upside. The forecast is based on price targets from 14 Wall Street analysts.

CGEM Analyst Rating
Based on 12 analysts

avg. 4.92 of 5
Strong buy
11 92%
Buy
1 8%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate CGEM Strong buy, with 12 of 12 recommending Buy or Strong buy.

Cullinan Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CGEM's stock price target?
Price Target
36.21 USD

According to Wall Street analysts, the average 1-year price target for CGEM is 36.21 USD with a low forecast of 27.27 USD and a high forecast of 55.65 USD.

Back to Top